The $762 Million Settlement: Inside the Amgen Whistleblower Case
In December 2012, pharmaceutical giant Amgen agreed to pay $762 million to resolve criminal and civil liability arising from illegal drug marketing practices. Ten whistleblowers came forward with evidence of off-label promotion and kickbacks.
Guest: Former DOJ Attorney